NCAPG Is a Promising Therapeutic Target Across Different Tumor Types

BACKGROUND: With the advent of CRISPR-Cas9 genome editing tool in gene therapy, identification of aberrantly expressed genes is of great value across various cancer types. Since a large number of patients may benefit from molecular targeted gene therapy. The purpose of this study was to identify abe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Cuicui, Gong, Jiao, Jie, Yusheng, Cao, Jing, Chen, Zhongcheng, Li, Rong, Chong, Yutian, Hu, Bo, Zhang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142249/
https://www.ncbi.nlm.nih.gov/pubmed/32300299
http://dx.doi.org/10.3389/fphar.2020.00387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142249/
https://www.ncbi.nlm.nih.gov/pubmed/32300299
http://dx.doi.org/10.3389/fphar.2020.00387

Ejemplares similares